Regeneron Pharmaceuticals (REGN)

Investing Cash Flow

-$704.20M

TTM · Period ending: · USD

REGN logo

REGN Investing Cash Flow

Latest reported-$704.20M
REGN TTM Cash from Investing ($8.20M → -$704.20M)
High-resolution chart · PNG

REGN investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-87,883,000
-53,298,000
-57,676,000
-49,843,000
6,417,000
10,209,000
17,500,000
27,500,000
12,900,000
17,200,000
2,400,000
-14,100,000
-19,100,000
-41,700,000
-38,900,000
-37,900,000
-32,600,000
-32,800,000
-44,300,000
-28,900,000
-24,400,000
-2,400,000
7,400,000
22,800,000
25,500,000
23,600,000
31,900,000
-4,100,000
-20,900,000
-20,500,000
-23,600,000
-2,600,000
11,700,000
7,500,000
8,200,000
-2,400,000
-5,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.